220 related articles for article (PubMed ID: 8105477)
21. The transcription factor MZF1 differentially regulates murine
Zhang S; Shi W; Ramsay ES; Bliskovsky V; Eiden AM; Connors D; Steinsaltz M; DuBois W; Mock BA
J Biol Chem; 2019 Nov; 294(45):16756-16764. PubMed ID: 31548308
[TBL] [Abstract][Full Text] [Related]
22. Fine chromosomal localization of the mouse Par2 gene that confers resistance against urethane-induction of pulmonary adenomas.
Lee GH; Matsushita H; Kitagawa T
Oncogene; 2001 Jul; 20(30):3979-85. PubMed ID: 11494126
[TBL] [Abstract][Full Text] [Related]
23. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
Coleman AE; Schröck E; Weaver Z; du Manoir S; Yang F; Ferguson-Smith MA; Ried T; Janz S
Cancer Res; 1997 Oct; 57(20):4585-92. PubMed ID: 9377573
[TBL] [Abstract][Full Text] [Related]
24. Genetics of susceptibility to plasmacytoma induction. I. BALB/cAnN (C), C57BL/6N (B6), C57BL/Ka (BK), (C times B6)F1, (C times BK)F1, and C times B recombinant-inbred strains.
Potter M; Pumphrey JG; Bailey DW
J Natl Cancer Inst; 1975 Jun; 54(6):1413-7. PubMed ID: 1133851
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous development of plasmacytomas in a selected subline of BALB/cJ mice.
Silva S; Wang Y; Babonits M; Imreh S; Wiener F; Klein G
Eur J Cancer; 1997 Mar; 33(3):479-85. PubMed ID: 9155535
[TBL] [Abstract][Full Text] [Related]
26. Differences in the molecular structure of c-myc-activating recombinations in murine plasmacytomas and precursor cells.
Müller JR; Potter M; Janz S
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):12066-70. PubMed ID: 7991585
[TBL] [Abstract][Full Text] [Related]
27. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
[TBL] [Abstract][Full Text] [Related]
28. A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus.
Mock B; Krall M; Blackwell J; O'Brien A; Schurr E; Gros P; Skamene E; Potter M
Genomics; 1990 May; 7(1):57-64. PubMed ID: 1970800
[TBL] [Abstract][Full Text] [Related]
29. Association of elevated mutagenesis in the spleen with genetic susceptibility to induced plasmacytoma development in mice.
Felix K; Kelliher K; Bornkamm GW; Janz S
Cancer Res; 1998 Apr; 58(8):1616-9. PubMed ID: 9563470
[TBL] [Abstract][Full Text] [Related]
30. A susceptibility locus for radiation lymphomagenesis on mouse chromosome 16.
Mori N; Okumoto M; Yamate J
J Radiat Res; 2000 Dec; 41(4):367-72. PubMed ID: 11329885
[TBL] [Abstract][Full Text] [Related]
31. Localization of a novel chromosome 7 locus that suppresses development of N-Methyl-N-nitrosourea-induced murine thymic lymphomas.
Angel JM; Morizot DC; Richie ER
Mol Carcinog; 1993; 7(3):151-6. PubMed ID: 8098217
[TBL] [Abstract][Full Text] [Related]
32. Identification of genes controlling collagen-induced arthritis in mice: striking homology with susceptibility loci previously identified in the rat.
Yang HT; Jirholt J; Svensson L; Sundvall M; Jansson L; Pettersson U; Holmdahl R
J Immunol; 1999 Sep; 163(5):2916-21. PubMed ID: 10453039
[TBL] [Abstract][Full Text] [Related]
33. Chromosomes 1 and 5 harbor plasmacytoma progressor genes in mice.
Coleman AE; Ried T; Janz S
Genes Chromosomes Cancer; 2000 Sep; 29(1):70-4. PubMed ID: 10918396
[TBL] [Abstract][Full Text] [Related]
34. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer.
Moen CJ; Groot PC; Hart AA; Snoek M; Demant P
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1082-6. PubMed ID: 8577718
[TBL] [Abstract][Full Text] [Related]
35. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.
Walker MC; Phillips-Quagliata JM
J Immunol; 1979 Apr; 122(4):1535-43. PubMed ID: 448097
[TBL] [Abstract][Full Text] [Related]
36. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
Silva S; Babonits M; Klein G
Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
[TBL] [Abstract][Full Text] [Related]
37. Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice.
Teuscher C; Rhein DM; Livingstone KD; Paynter RA; Doerge RW; Nicholson SM; Melvold RW
J Immunol; 1997 Nov; 159(10):4930-4. PubMed ID: 9366418
[TBL] [Abstract][Full Text] [Related]
38. Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.
Symons RC; Daly MJ; Fridlyand J; Speed TP; Cook WD; Gerondakis S; Harris AW; Foote SJ
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11299-304. PubMed ID: 12149518
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel genetic loci contributing to 12-O-tetradecanoylphorbol-13-acetate skin tumor promotion susceptibility in DBA/2 and C57BL/6 mice.
Angel JM; Caballero M; DiGiovanni J
Cancer Res; 2003 Jun; 63(11):2747-51. PubMed ID: 12782578
[TBL] [Abstract][Full Text] [Related]
40. Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain.
Potter M; Wax J; Jones GM
Blood; 1997 Jul; 90(1):260-9. PubMed ID: 9207461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
